Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in AXGN — Axogen, Inc.

CIK 19617 NEW YORK, NY
Back to AXGN Full portfolio

Position in AXGN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$8,268,054
+$2,054,889 QoQ
Shares Held
179,001
-4.6% QoQ
Ownership
0.333%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 253 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 81% Shared 0% None 19%

Common Shares in AXGN Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $14,280,901,445 across 102 Medical Devices names. AXGN ranks #28 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 SYK
Stryker Corp
 17,260,943 $5,434,435,284
2 MDT
Medtronic plc
 27,784,471 $2,173,579,157
3 EW
Edwards Lifesciences Corp
 22,783,175 $2,060,966,003
4 ABT
Abbott Laboratories
 15,095,898 $1,369,801,775
5 BSX
Boston Scientific Corp
 23,907,838 $1,020,386,517
6 GEHC
GE HealthCare Technologies Inc.
 10,329,164 $661,169,779
7 PEN
Penumbra Inc
 1,071,454 $338,311,597
8 DXCM
Dexcom Inc
 3,325,095 $223,945,140

All Filings in AXGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,268,054 179,001
2026-03-31 $6,213,165 187,539
2025-12-31 $9,376,915 286,493
2025-09-30 $3,728,612 209,003
2025-06-30 $4,112,907 379,070
2025-03-31 $5,105,963 275,998
2024-12-31 $5,118,158 310,568
2024-09-30 $7,696,978 549,000
2024-06-30 $131,948 18,225
2024-03-31 $132,501 16,419
2023-12-31 $183,706 26,897
2023-09-30 $139,055 27,811
2023-06-30 $295,984 32,419
2023-03-31 $301,936 31,951
2022-12-31 $238,640 23,912
2022-09-30 $265,815 22,300
2022-06-30 $178,967 21,852
2022-03-31 $146,722 18,479
2021-12-31 $141,318 15,082
2021-09-30 $377,808 23,912
2021-06-30 $496,834 22,991
2021-03-31 $1,179,212 58,204
2020-12-31 $5,153,909 287,928
2020-09-30 $1,589,378 136,662
2020-06-30 $1,343,495 145,400
2020-03-31 $1,657,552 159,380